F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatic steatosis

Page 1 of 2 ( 67 items )
<<
1
2
>>

1	Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer 3/16/2026 8:22:56 AM \| Browse: 106 \| Download: 469
2	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 161 \| Download: 523
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 170 \| Download: 524
4	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 223 \| Download: 428
5	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 209 \| Download: 632
6	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 428 \| Download: 738
7	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 397 \| Download: 765
8	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 359 \| Download: 610
9	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 188 \| Download: 527
10	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 176 \| Download: 720
11	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 272 \| Download: 1149
12	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 229 \| Download: 998
13	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 357 \| Download: 848
14	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 346 \| Download: 925
15	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 307 \| Download: 822
16	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 274 \| Download: 928
17	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 380 \| Download: 1491
18	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 196 \| Download: 879
19	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 372 \| Download: 1274
20	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 664 \| Download: 1638
21	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 750 \| Download: 1623
22	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 721 \| Download: 1780
23	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 770 \| Download: 2505
24	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 983 \| Download: 1680
25	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 941 \| Download: 2121
26	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1125 \| Download: 2061
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 1004 \| Download: 1843
28	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 963 \| Download: 2412
29	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 948 \| Download: 2010
30	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 646 \| Download: 1701
31	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 835 \| Download: 2407
32	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 986 \| Download: 2064
33	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 1093 \| Download: 2748
34	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1369 \| Download: 2815
35	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 1030 \| Download: 3113
36	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1435 \| Download: 3001
37	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1501 \| Download: 2666
38	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1551 \| Download: 3024
39	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 1135 \| Download: 2503
40	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1977 \| Download: 2516
41	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1623 \| Download: 2607
42	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1833 \| Download: 3024
43	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1465 \| Download: 3209
44	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1718 \| Download: 2927
45	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1867 \| Download: 3554
46	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1573 \| Download: 2457
47	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 2061 \| Download: 4113
48	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1574 \| Download: 2110
49	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1689 \| Download: 2248
50	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 2040 \| Download: 3548

Page 1 of 2 ( 67 items )
<<
1
2
>>

1	Impact of metabolic dysfunction-associated steatotic liver disease on liver metastasis and survival in pancreatic cancer 3/16/2026 8:22:56 AM \| Browse: 106 \| Download: 469
2	Evaluation methods of hepatic steatosis: From conventional techniques to emerging biomarkers 1/27/2026 10:12:31 AM \| Browse: 161 \| Download: 523
3	Gluten’s silent strike: Unmasking its impact on liver health 12/22/2025 7:43:02 AM \| Browse: 170 \| Download: 524
4	Fatty liver reexamined choline and mitochondrial toxin amelioration 12/4/2025 6:40:47 AM \| Browse: 223 \| Download: 428
5	Machine learning to predict metabolic-associated fatty liver disease 12/3/2025 9:10:07 AM \| Browse: 209 \| Download: 632
6	Bile acids in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:12 AM \| Browse: 428 \| Download: 738
7	Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease 8/27/2025 9:21:11 AM \| Browse: 397 \| Download: 765
8	Copper and hepatic lipid dysregulation: Mechanisms and implications 8/27/2025 9:21:08 AM \| Browse: 359 \| Download: 610
9	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 188 \| Download: 527
10	Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk 7/21/2025 9:42:33 AM \| Browse: 176 \| Download: 720
11	Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence 6/12/2025 3:45:50 AM \| Browse: 272 \| Download: 1149
12	Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation 4/29/2025 9:13:41 AM \| Browse: 229 \| Download: 998
13	Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital 4/25/2025 8:23:05 AM \| Browse: 357 \| Download: 848
14	Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease 2/14/2025 10:33:16 AM \| Browse: 346 \| Download: 925
15	Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway 1/20/2025 7:38:46 AM \| Browse: 307 \| Download: 822
16	Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 10/21/2024 7:03:24 AM \| Browse: 274 \| Download: 928
17	Hepatoprotective effects of Xiaoyao San formula on hepatic steatosis and inflammation via regulating the sex hormones metabolism 7/26/2024 10:33:30 AM \| Browse: 380 \| Download: 1491
18	Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease 5/22/2024 11:33:24 AM \| Browse: 196 \| Download: 879
19	Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis 10/24/2023 7:40:57 AM \| Browse: 372 \| Download: 1274
20	Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas 7/10/2023 8:58:21 AM \| Browse: 664 \| Download: 1638
21	Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications 5/7/2023 7:47:34 AM \| Browse: 750 \| Download: 1623
22	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 721 \| Download: 1780
23	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 770 \| Download: 2505
24	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 983 \| Download: 1680
25	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 941 \| Download: 2121
26	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 1125 \| Download: 2061
27	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 1004 \| Download: 1843
28	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 963 \| Download: 2412
29	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 948 \| Download: 2010
30	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 646 \| Download: 1701
31	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 835 \| Download: 2407
32	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 986 \| Download: 2064
33	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 1093 \| Download: 2748
34	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 1369 \| Download: 2815
35	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 1030 \| Download: 3113
36	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 1435 \| Download: 3001
37	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 1501 \| Download: 2666
38	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 1551 \| Download: 3024
39	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 1135 \| Download: 2503
40	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1977 \| Download: 2516
41	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 1623 \| Download: 2607
42	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1833 \| Download: 3024
43	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 1465 \| Download: 3209
44	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1718 \| Download: 2927
45	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1867 \| Download: 3554
46	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1573 \| Download: 2457
47	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 2061 \| Download: 4113
48	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1574 \| Download: 2110
49	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1689 \| Download: 2248
50	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 2040 \| Download: 3548